OBJECTIVES The aim of this study was to determine if noninvasive measurement of scar by contrast-enhanced magnetic resonance imaging (MRI)-based signal intensity (SI) mapping predicts ventricular tachycardia (VT) recurrence after endocardial ablation.
. These findings may be related to the fact that in patients with large scars, either the complete VT substrate ablation is more difficult to achieve or epicardial VT substrate is more likely (5, 6 ).
Contrast-enhanced magnetic resonance imaging (MRI) is an accurate technique to
identify scar and differentiate dense scar from heterogeneous tissue (HT) (7, 8) . Both scar and HT extension, analyzed by contrast-enhanced MRI, have proved more valuable for arrhythmogenic risk stratification than left ventricular ejection fraction (LVEF) (9) (10) (11) . Left ventricular signal intensity (SI) mapping, in which subendocardial and subepicardial SI is averaged and projected onto 3-dimensional (3D) reconstructions of the endocardial and epicardial surfaces, has good correlation with electroanatomic mapping and allows measurement of the extension of endocardial and epicardial HT and scar (12) (13) (14) .
We hypothesized that the extent of endocardial scar and the presence of epicardial involvement, as assessed by contrast-enhanced MRI-based SI mapping, could determine the risk for VT recurrence after substrate ablation. and HT (i.e., gray zone) mass was quantified by 2 previously described methods: 1) the full width at half maximum (11, 15) ; and 2) on the basis of SDs of the SI from the remote mean healthy myocardium (>2 SDs defined the total infarct mass, >3 SDs the core infarct, and HT between 2 and 3 SDs) (10, 16) .
M a g n e t i c r e s o n a n c e -b a s e d e n d o -e p i c a r d i a l S I m a p p i n g . The myocardial wall was divided into 2 equal parts: subendocardium and subepicardium.
The averaged SI of each part was projected respectively onto 3D endocardial and epicardial shell reconstructions of the left ventricle to identify the endocardial and epicardial VT substrate. To achieve this, the left ventricular endocardial and epicardial contours were manually defined on contiguous shortaxis slices using QMass MR 7.0 (Medis Medical Imaging, Leiden, the Netherlands) and imported into our tool. Three-dimensional endocardial and epicardial reconstructions were computed off-line from a short-axis contrast-enhanced MRI image volume Ávila et al.
using custom software developed in the MATLAB environment (The MathWorks, Natick, Massachusetts). The 3D visualization interface was implemented in Java (Sun Microsystems, Santa Clara, California) using VTK (Kitware, Clifton Park, New York) visualization algorithms (12) . The 2 surface maps and short-axis slices were analyzed to determine the structure of the scar and HT in the ventricular wall (endo-epicardial SI mapping). These surfaces were color-coded to provide information on SI: the red area represented dense scar and was defined by an SI greater than or equal to the minimal SI in the core of the scar, the magenta area represented normal myocardium (SI less than or equal to SI peak in the normal myocardium), and the area between these extremes represented HT. On all mapping surfaces, the extension of scar, dense scar, and HT was measured using custom-developed software. We also measured the number of HT channels, which were defined as corridors of HT differentiated from the surrounding scar tissue by lower SI (12) . SI processing and measurements were performed in a core laboratory at Gregorio Marañón Hospital, blinded to follow-up data. Values are mean AE SD, n (%), or median (interquartile range).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; EPS ¼ electrophysiological study; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; NYHA ¼ New York Heart Association; TIA ¼ transient ischemic attack; VT ¼ ventricular tachycardia. receiver-operating characteristic curve analysis (19) .
Scar and HT areas in both endocardium and epicardium were then categorized as large or small using these cutoff values. Kaplan-Meier analysis was used to estimate the event-free rates, and log-rank tests Ávila et al.
were used to estimate survival differences. All ana- 
VT and ICD therapy. Cumulative arrhythmia-free survival was 78% at 1 year, 62% at 3 years, and 40% at 5 years. No patients were lost to follow-up, but 4 died, 1 of heart failure and 3 of noncardiac causes.
One patient had VT storm. Ablation was repeated in 9 patients with recurrent episodes and ICD shocks; an epicardial approach was performed in 5 of these patients.
COMPARISON OF PATIENTS WITH AND WITHOUT VT
RECURRENCE. No significant differences were found in the demographic characteristics of patients with recurrences at the end of follow-up compared with those without recurrence ( Figures 3 to 5) .
Results from the univariate and multivariate analyses are reported in Table 4 . Ávila et al. Values are mean AE SD. HT ¼ heterogeneous.
Ávila et al. Note the small endocardial scar extension in both the electroanatomic (A1, A2) and endocardial signal intensity (SI) maps (B1, B2) as well as the small epicardial involvement in the epicardial SI maps (C1, C2). Dense scar, heterogeneous tissue, and healthy tissue areas in all the SI maps are presented.
Ávila et al. In fact, successful ablation zones appear to be localized in areas of HT, and incomplete ablation in these areas predicted VT recurrence in animal experimental models (23) . Perez-David et al. (12) showed a significant correlation in endocardial scar extension detected by SI mapping and electroanatomic mapping as well as in VT-related CC and HT channels (12) , findings that were confirmed in later studies (13, 14, 24) . Tables 1 to 3 .
Ávila et al. who may benefit from VT ablation (i.e., those with small scars) (1, 2) . It may also aid in selecting patients in whom not to extend the substrate ablation to the epicardium, thus avoiding unnecessary epicardial explorations. This is very relevant, as in a previous study, more than 65% of pericardial mappings were not followed by ablation (21) .
Epicardial mapping is thus probably not indicated in patients if little or no epicardial scar is present, even when previous endocardial ablation has Ávila et al. patients with ischemic heart disease were included in this study, so it is unknown if these results could be applied to patients with SMVT due to other cardiomyopathies. Patients with nonischemic cardiomyopathy were excluded, because our algorithm for obtaining SI maps has not been yet validated in that population.
CONCLUSIONS
Quantification of endocardial and epicardial scar noninvasively by pre-procedural contrast-enhanced MRI-based SI mapping is useful to identify those patients with a higher probability of long-term VT recurrence after complete endocardial substrate ablation. This information could be used for patient selection and to determine the ablation strategy and approach.
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